[Report]: Feb’14 Pharmaceutical alpha stock – Good Company and great valuations

Feb’14 Alpha stock – A good Pharma company with great valuations Dear Readers, On 25th Feb’14 we released long/medium term investment recommendation for our Alpha and Alpha + members and would like to share with you details on the same especially if you like our research and our focus on high quality companies run by good management. Our last recommendation from Pharmaceutical Industry was IPCA Laboratories in Nov’12 at Rs 445 and the stock has appreciated by 100% since then to current…

Read More

CARE Rating – Getting re-rated with PE funds negotiating for a majority stake at 900-1000

Dear Readers, CARE Rating (NSE Code – CARERATING) was recommended to Alpha and Alpha plus members in Aug’13 when the stock was around 525. The detailed report on the same was also made public on 16th Nov’13 when the stock was around 700 (CMP – 850). In case you have invested in CARE, here’s an important update regarding the latest developments in the company. The Company recently informed exchanges that its principal shareholders, IDBI, along with four other shareholders, who hold…

Read More
Copy Protected by Chetan's WP-Copyprotect.